Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce G Robinson

Showing results (71-80 of 141) with videos related to

Pageof 15
Sort By:
The Journal of Clinical Endocrinology and Metabolism|January 17, 2022
Surveillance Improves Outcomes for Carriers of SDHB Pathogenic Variants: A Multicenter StudyDahlia F Davidoff, Diana E Benn, Michael Field, et al.
The Journal of Clinical Endocrinology and Metabolism|June 28, 2012
Association of FOXE1 polyalanine repeat region with papillary thyroid cancerMartyn Bullock, Emma L Duncan, Christine O'Neill, et al.
The Oncologist|March 29, 2019
microRNA-431 as a Chemosensitizer and Potentiator of Drug Activity in Adrenocortical CarcinomaGrace T Y Kwok, Jing Ting Zhao, Anthony R Glover, et al.
The Journal of Clinical Endocrinology and Metabolism|November 20, 2008
Accuracy of combined protein gene product 9.5 and parafibromin markers for immunohistochemical diagnosis of parathyroid carcinomaViive M Howell, Anthony Gill, Adele Clarkson, et al.
Annals of Surgical Oncology|September 30, 2010
Medullary thyroid carcinoma: long-term outcomes of surgical treatmentDeepak T Abraham, Tsu-Hui Low, Marinella Messina, et al.
The American Journal of Surgical Pathology|March 15, 2014
Succinate dehydrogenase deficiency is rare in pituitary adenomasAnthony J Gill, Christopher W Toon, Adele Clarkson, et al.
Endocrine Oncology (Bristol, England)|June 25, 2025
Real-world lenvatinib use in metastatic thyroid cancer: early dose intensity and side effect profile in an Australian centreMonica Majumder, Shejil Kumar, Tony Lian, et al.
ANZ Journal of Surgery|July 2, 2009
Outcomes of minimally invasive surgery for phaeochromocytomaGoswin Y Meyer-Rochow, Patsy S H Soon, Leigh W Delbridge, et al.
The Journal of Clinical Endocrinology and Metabolism|January 23, 2009
Nuclear accumulation of e-cadherin correlates with loss of cytoplasmic membrane staining and invasion in pituitary adenomasMarianne S Elston, Anthony J Gill, John V Conaglen, et al.
The Oncologist|February 7, 2015
Immunohistochemical validation of overexpressed genes identified by global expression microarrays in adrenocortical carcinoma reveals potential predictive and prognostic biomarkersJulian C Y Ip, Tony C Y Pang, Anthony R Glover, et al.
Pageof 15

Showing results (71-80 of 141) with videos related to

Sort By:
Pageof 15
The Journal of Clinical Endocrinology and Metabolism|January 17, 2022
Surveillance Improves Outcomes for Carriers of SDHB Pathogenic Variants: A Multicenter StudyDahlia F Davidoff, Diana E Benn, Michael Field, et al.
The Journal of Clinical Endocrinology and Metabolism|June 28, 2012
Association of FOXE1 polyalanine repeat region with papillary thyroid cancerMartyn Bullock, Emma L Duncan, Christine O'Neill, et al.
The Oncologist|March 29, 2019
microRNA-431 as a Chemosensitizer and Potentiator of Drug Activity in Adrenocortical CarcinomaGrace T Y Kwok, Jing Ting Zhao, Anthony R Glover, et al.
The Journal of Clinical Endocrinology and Metabolism|November 20, 2008
Accuracy of combined protein gene product 9.5 and parafibromin markers for immunohistochemical diagnosis of parathyroid carcinomaViive M Howell, Anthony Gill, Adele Clarkson, et al.
Annals of Surgical Oncology|September 30, 2010
Medullary thyroid carcinoma: long-term outcomes of surgical treatmentDeepak T Abraham, Tsu-Hui Low, Marinella Messina, et al.
The American Journal of Surgical Pathology|March 15, 2014
Succinate dehydrogenase deficiency is rare in pituitary adenomasAnthony J Gill, Christopher W Toon, Adele Clarkson, et al.
Endocrine Oncology (Bristol, England)|June 25, 2025
Real-world lenvatinib use in metastatic thyroid cancer: early dose intensity and side effect profile in an Australian centreMonica Majumder, Shejil Kumar, Tony Lian, et al.
ANZ Journal of Surgery|July 2, 2009
Outcomes of minimally invasive surgery for phaeochromocytomaGoswin Y Meyer-Rochow, Patsy S H Soon, Leigh W Delbridge, et al.
The Journal of Clinical Endocrinology and Metabolism|January 23, 2009
Nuclear accumulation of e-cadherin correlates with loss of cytoplasmic membrane staining and invasion in pituitary adenomasMarianne S Elston, Anthony J Gill, John V Conaglen, et al.
The Oncologist|February 7, 2015
Immunohistochemical validation of overexpressed genes identified by global expression microarrays in adrenocortical carcinoma reveals potential predictive and prognostic biomarkersJulian C Y Ip, Tony C Y Pang, Anthony R Glover, et al.
Pageof 15